Efficient bioconversion of high-concentration d-fructose into d-mannose by a novel N-acyl-d-glucosamine 2-epimerase from Thermobifida halotolerans

The synthesis of mannose is of great value because it is the only glyconutrient used for clinical applications. Here, we performed the enzymatic bioconversion of d-fructose to d-mannose using a recombinant thermostable N-acyl-d-glucosamine 2-epimerase (ThMI) from a Thermobifida halotolerans engineered strain. The enzymatic bioconversion produced 180 g L(-1)d-mannose from high-concentration d-fructose (500 g L-1) in 1 h by recombinant ThMI, resulting in a maximum bioconversion ratio of 35.8%. The recombinant resting cells at a density of 10 OD600 produced 157 g L(-1)d-mannose from 500 g L(-1)d-fructose in 1 h. These results suggest that the novel biocatalyst system developed in this study can be applied for large-scale industrial production of d-mannose.

Automated summary

This study successfully demonstrated the enzymatic bioconversion of d-fructose to d-mannose using a recombinant thermostable N-acyl-d-glucosamine 2-epimerase, resulting in high yields of d-mannose within 1 hour. The newly developed biocatalyst system shows potential for large-scale industrial production of d-mannose.